Evidence map›Paper›PMID 39723845›Full record

ArticleEpilepsia2025

Can the large language model ChatGPT-4omni predict outcomes in adult patients with status epilepticus?

Simon A Amacher, Sira M Baumann, Sebastian Berger, Armon Arpagaus, Simon B Egli, Pascale Grzonka, Paulina S C Kliem, Sabina Hunziker, Urs Fisch, Caroline E Gebhard and 1 more

Abstract read
In one paragraph

Article in Epilepsia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Simon A AmacherClinic for Intensive Care Medicine, Department of Acute Care, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0001-6530-1240
Sira M BaumannClinic for Intensive Care Medicine, Department of Acute Care, University Hospital Basel, Basel, Switzerland.
Sebastian BergerClinic for Intensive Care Medicine, Department of Acute Care, University Hospital Basel, Basel, Switzerland.
Armon ArpagausMedical Communication and Psychosomatic Medicine, University Hospital Basel, Basel, Switzerland.
Simon B EgliDepartment of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Pascale GrzonkaClinic for Intensive Care Medicine, Department of Acute Care, University Hospital Basel, Basel, Switzerland.
Paulina S C KliemClinic for Intensive Care Medicine, Department of Acute Care, University Hospital Basel, Basel, Switzerland.
Sabina HunzikerMedical Communication and Psychosomatic Medicine, University Hospital Basel, Basel, Switzerland.
Urs FischDepartment of Neurology, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-1557-9062
Caroline E GebhardClinic for Intensive Care Medicine, Department of Acute Care, University Hospital Basel, Basel, Switzerland.
Raoul SutterClinic for Intensive Care Medicine, Department of Acute Care, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-6575-356X

Funding

University Hospital Basel
6 · The paper itself

Abstract

objectiveLarge language models (LLMs) have recently gained attention for clinical decision-making and diagnosis. This study evaluates the performance of the recently updated LLM Chat Generative Pre-Trained Transformer-4omni (ChatGPT-4o) in predicting clinical outcomes in patients with status epilepticus and compares its prognostic performance to the Status Epilepticus Severity Score (STESS).

methodsThis retrospective single-center cohort study was performed at the University Hospital Basel (tertiary academic medical center) from January 2005 to December 2022. It included consecutive adult patients (≥18 years of age) with a diagnosis of status epilepticus. The primary outcome was survival at hospital discharge, and the secondary outcome was return to premorbid neurological function at hospital discharge. The performance characteristics of ChatGPT4-o (sensitivity, specificity, Youden Index) were evaluated and compared to those of the STESS.

resultsOf 760 patients, 689 patients (90.7%) survived to discharge, and 317 survivors (41.7%) regained their premorbid neurological function at discharge. ChatGPT-4o predicted survival in 567 of 760 patients (74.6%), of which 45 died. ChatGPT-4o predicted death in 193 of 760 patients (25.4%), of which 167 survived, resulting in a sensitivity of 75.8% and a specificity of 36.6% (Youden Index 0.12, 95% confidence interval [CI] 0-.28) for predicting survival. ChatGPT-4o predicted return to premorbid neurologic function in 249 of 760 patients (32.8%), of which 112 did not return to their premorbid neurological function. ChatGPT-4o predicted no return to premorbid function in 511 of 760 patients (67.2%), of which 180 returned to their premorbid function, resulting in a sensitivity of 43.2% and a specificity of 74.7% (Youden Index .12, 95% CI .08-.28) for predicting return to premorbid neurological function. There was no difference in the prognostic performance of ChatGPT-4o and the STESS. A second round of prompting did not increase the predictive performance of ChatGPT-4o. SIGNIFICANCE: ChatGPT-4o unreliably predicts outcomes in patients with status epilepticus. Clinicians should refrain from using ChatGPT-4o for prognostication in these patients.

Indexed as

Status EpilepticusAdultAgedCohort StudiesFemaleGenerative Artificial IntelligenceHumansLarge Language ModelsMaleMiddle AgedPredictive Value of TestsPrognosisRetrospective StudiesSeverity of Illness IndexYoung Adultartificial intelligencelarge language modelsneurocritical careoutcome predictionstatus epilepticus

Identifiers

PMID39723845
PMCPMC11908661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.